0001127602-20-009831.txt : 20200306 0001127602-20-009831.hdr.sgml : 20200306 20200306162605 ACCESSION NUMBER: 0001127602-20-009831 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200304 FILED AS OF DATE: 20200306 DATE AS OF CHANGE: 20200306 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MACKAY GEOFFREY CENTRAL INDEX KEY: 0001741849 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38537 FILM NUMBER: 20695089 MAIL ADDRESS: STREET 1: C/O AVROBIO, INC. STREET 2: ONE KENDALL SQ, BLDG. 300, STE. 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVROBIO, Inc. CENTRAL INDEX KEY: 0001681087 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 810710585 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 7819626030 MAIL ADDRESS: STREET 1: ONE KENDALL SQUARE STREET 2: BLDG. 300, SUITE 201 CITY: CAMBRIDGE STATE: MA ZIP: 02139 FORMER COMPANY: FORMER CONFORMED NAME: AvroBio, Inc. DATE OF NAME CHANGE: 20160729 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-03-04 0001681087 AVROBIO, Inc. AVRO 0001741849 MACKAY GEOFFREY C/O AVROBIO, INC. ONE KENDALL SQUARE, BLDG. 300, SUITE 201 CAMBRIDGE MA 02139 1 1 President & CEO Stock Option (Right to Buy) 21.44 2020-03-04 4 A 0 292300 0 A 2030-03-03 Common Stock 292300 292300 D 25% of the shares shall vest and become exercisable on March 4, 2021, and the remaining 75% shall vest in equal monthly installments thereafter over a 3 year period. /s/ Steven N. Avruch, Attorney-in-Fact for Geoffrey MacKay 2020-03-06